A validated method for the analysis of cannabinoids in post-mortem blood using liquid-liquid extraction and two-dimensional gas chromatography-mass spectrometry.

[1]  M. Huestis,et al.  Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH). , 2011, Forensic science international.

[2]  M. Huestis,et al.  Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration. , 2011, Clinical chemistry.

[3]  N. Lemos,et al.  Cannabinoids in postmortem toxicology. , 2011, Journal of analytical toxicology.

[4]  G. Skopp,et al.  A preliminary investigation on the distribution of cannabinoids in man. , 2011, Forensic science international.

[5]  M. Chiarotti,et al.  LC-MS-MS method for simultaneous determination of THCCOOH and THCCOOH-glucuronide in urine: Application to workplace confirmation tests. , 2011, Forensic science international.

[6]  M. Huestis,et al.  Validation of a two-dimensional gas chromatography mass spectrometry method for the simultaneous quantification of cannabidiol, Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in plasma , 2010, Analytical and bioanalytical chemistry.

[7]  M. Huestis,et al.  Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry. , 2010, Journal of chromatography. A.

[8]  R. Herning,et al.  Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users? , 2009, Addiction.

[9]  R. Herning,et al.  Intra- and intersubject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing. , 2009, Clinical chemistry.

[10]  G. McMillin,et al.  Confirmation of cannabinoids in meconium using two-dimensional gas chromatography with mass spectrometry detection. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[11]  M. Huestis,et al.  Simultaneous quantification of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry. , 2007, Journal of chromatography. A.

[12]  A. Verstraete,et al.  Validated method for the simultaneous determination of Delta9-THC and Delta9-THC-COOH in oral fluid, urine and whole blood using solid-phase extraction and liquid chromatography-mass spectrometry with electrospray ionization. , 2007, Forensic science international.

[13]  J. Drewe,et al.  Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of Cannabis sativa extracts. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[14]  N. Samyn,et al.  Correlation of Delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Dräger DrugTest. , 2006, Forensic science international.

[15]  S. Rana,et al.  Analytical procedure for the determination of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens. , 2006, Journal of analytical toxicology.

[16]  R. Scurlock,et al.  The Detection of Δ9-Tetrahydrocannabinol (THC) and 11-nor-9-Carboxy-Δ9-Tetrahydrocannabinol (THCA) in Whole Blood Using Two-Dimensional Gas Chromatography and El-Mass Spectrometry , 2006 .

[17]  S. Rana,et al.  Application of two-dimensional gas chromatography with electron capture chemical ionization mass spectrometry to the detection of 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) in hair. , 2006, Journal of analytical toxicology.

[18]  T. Buclin,et al.  Δ9-THC, 11-OH-Δ9-THC and Δ9-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people , 2001 .

[19]  M. Huestis,et al.  Simultaneous Determination of Δ9-Tetrahydrocannabinol and 11-nor-9-Carboxy-Δ9-Tetrahydrocannabinol in Human Plasma by Solid-Phase Extraction and Gas Chromatography-Negative Ion Chemical Ionization-Mass Spectrometry , 2001 .

[20]  C. Goodall,et al.  A reliable method for the detection, confirmation, and quantitation of cannabinoids in blood. , 1995, Journal of analytical toxicology.

[21]  M. Huestis,et al.  Detection times of marijuana metabolites in urine by immunoassay and GC-MS. , 1995, Journal of analytical toxicology.

[22]  P. Kemp,et al.  Cannabinoids in humans. I. Analysis of delta 9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS. , 1995, Journal of analytical toxicology.

[23]  R. Foltz,et al.  Quantitative measurement of Δ9-tetrahydrocannabinol and two major metabolites in physiological specimens using capillary column gas chromatography negative ion chemical ionization mass spectrometry , 1983 .

[24]  S. Paterson,et al.  Production of identical retention times and mass spectra for {delta}9-tetrahydrocannabinol and cannabidiol following derivatization with trifluoracetic anhydride with 1,1,1,3,3,3-hexafluoroisopropanol*. , 2012, Journal of analytical toxicology.

[25]  AC Moffat,et al.  Clarke's analysis of drugs and poisons , 2003 .

[26]  M. Spain,et al.  Confirmation of 11-nor-delta 9-tetrahydrocannabinol in urine as its t-butyldimethylsilyl derivative using GC/MS. , 1993, Journal of analytical toxicology.